PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930027
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930027
Point of Care Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of point of care diagnostics Market
The global point of care diagnostics market size was valued at USD 32.87 billion in 2025 and is projected to grow to USD 34.47 billion in 2026, reaching USD 60.36 billion by 2034. The market is witnessing strong expansion due to rising demand for rapid testing solutions, decentralization of healthcare services, and increasing burden of chronic and infectious diseases. In 2025, North America dominated the market with a share of 35.6%, supported by high adoption of advanced diagnostic technologies and favorable reimbursement policies.
Point of care diagnostics refers to medical diagnostic testing performed near or at the site of patient care, enabling faster clinical decisions. These tests are widely used across hospitals, clinics, urgent care centers, and home settings for detecting glucose levels, infections, cardiac markers, pregnancy status, and hematological conditions. The ability to provide results within minutes significantly improves treatment efficiency and patient outcomes.
Market Drivers
One of the key drivers of the point of care diagnostics market is the rising adoption of multiplex testing platforms that can detect multiple pathogens from a single sample. These platforms reduce turnaround time and improve diagnostic accuracy, making them highly suitable for emergency care and infectious disease screening. Increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and kidney diseases is also fueling test volume growth, especially for blood-based diagnostics.
Healthcare systems are also increasingly focusing on early diagnosis and decentralized testing models, which supports the deployment of portable and easy-to-use diagnostic devices in community healthcare settings and rural regions.
Market Restraints
Despite technological progress, result consistency and reliability issues remain a significant restraint. Variations in device calibration, operator skill levels, and quality control standards can lead to inconsistent outcomes. Regulatory complexity and the need for extensive validation processes increase development timelines and manufacturing costs, particularly affecting small and mid-sized diagnostic companies seeking global expansion.
Market Opportunities
The integration of Internet of Things (IoT) and connected diagnostics offers strong growth opportunities. Connected POC devices enable real-time transmission of patient data to electronic health records and cloud-based systems, supporting remote monitoring and telehealth services. This capability is especially valuable for managing chronic diseases and post-treatment follow-ups, enhancing long-term patient engagement and healthcare efficiency.
Growing adoption of remote patient monitoring platforms is expected to further strengthen demand for digitally integrated diagnostic devices across both urban and rural healthcare networks.
Market Trends
A major emerging trend is the rising adoption of CRISPR-based point of care diagnostic tools. These technologies offer high sensitivity, faster detection, and minimal sample preparation, making them suitable for infectious disease screening and genetic testing. Increasing collaboration between biotechnology companies and academic institutions is accelerating innovation and commercialization of CRISPR diagnostics in portable testing formats.
Another important trend is the growing use of artificial intelligence in POC devices, enabling predictive analytics, automated result interpretation, and improved workflow integration in clinical settings.
Segmentation Analysis
By Product
The market is segmented into blood glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, hematology testing, and others. Blood glucose monitoring dominated the market in 2026 with a share of 54.93%, driven by the rising global prevalence of diabetes and increasing use of continuous glucose monitoring devices. Pregnancy and fertility testing is witnessing increasing adoption due to growing awareness of reproductive health and expanding access to self-testing kits.
By Sample
Based on sample type, the market includes blood, nasal and oropharyngeal swabs, urine, and others. Blood-based diagnostics accounted for 77.05% of the market in 2026, supported by its wide applicability in detecting infections, metabolic disorders, and organ function indicators. Urine testing is also growing due to rising cases of kidney disorders and urinary tract infections.
By End User
End users include hospital bedside, physician office labs, urgent care and retail clinics, and home and self-testing. Hospital bedside testing held 40.50% share in 2026, driven by increased adoption of rapid diagnostic tools in inpatient and emergency departments. Urgent care and retail clinics are expanding rapidly due to patient preference for faster and more accessible healthcare services.
Regional Outlook
North America generated USD 11.69 billion in 2025, supported by strong healthcare infrastructure and rapid product approvals. The U.S. market alone is projected to reach USD 10.7 billion by 2026. Europe continues to show steady growth, with Germany valued at USD 2.46 billion and the U.K. at USD 2.23 billion by 2026. Asia Pacific is expanding significantly due to rising healthcare investment, with China at USD 1.43 billion, Japan at USD 1.42 billion, and India at USD 1.87 billion by 2026. Latin America is growing due to improving healthcare access, while Middle East & Africa shows moderate growth supported by new diagnostic product launches.
Competitive Landscape
The point of care diagnostics market is semi-consolidated with major players including F. Hoffmann-La Roche Ltd., Abbott, Danaher Corporation, Thermo Fisher Scientific, BD, bioMerieux, and QuidelOrtho. These companies focus heavily on R&D investments, product innovation, and regulatory approvals to strengthen their market positions. New entrants are introducing AI-enabled and portable diagnostic platforms to address unmet clinical needs and expand access to rapid testing solutions.
Report Coverage
The point of care diagnostics market report provides an in-depth assessment of market size and value for the years 2025, 2026, and 2034, along with a comprehensive evaluation of industry structure, competitive positioning, and technological evolution. The report analyzes major product categories including blood glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, hematology testing, and other diagnostic applications used in near-patient testing environments. It further evaluates sample-based segmentation such as blood, urine, nasal and oropharyngeal swabs, and other biological samples used in point of care diagnostics.
The report includes detailed end-user analysis covering hospital bedside testing, physician office laboratories, urgent care and retail clinics, and home and self-testing environments. It assesses how healthcare delivery models and patient behavior are influencing demand patterns across institutional and consumer-based testing settings. Regional analysis covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with specific market values highlighted for the U.S., Germany, the U.K., China, Japan, and India for the year 2026, and regional market dominance discussed for 2025.
In addition, the report evaluates major market drivers such as rising chronic disease burden, increasing adoption of multiplex testing platforms, expansion of decentralized healthcare services, and technological advancements including connected diagnostics, artificial intelligence integration, and CRISPR-based diagnostic tools. Market restraints including regulatory complexity, result variability, and quality assurance challenges are assessed in detail. The study also reviews strategic initiatives such as product approvals, facility expansions, partnerships, and technological investments by leading manufacturers operating in the global point of care diagnostics market.
Conclusion
The global point of care diagnostics market demonstrates strong expansion potential from USD 32.87 billion in 2025 to USD 34.47 billion in 2026, reaching USD 60.36 billion by 2034, supported by rapid growth in near-patient testing adoption across both clinical and home-based settings. Increasing demand for faster diagnosis, early disease detection, and decentralized healthcare delivery continues to strengthen the role of point of care diagnostics in routine medical practice.
Technological innovation remains central to market development, with multiplex platforms, AI-enabled interpretation systems, connected diagnostic ecosystems, and CRISPR-based detection tools reshaping testing efficiency and accuracy. Blood-based diagnostics and blood glucose monitoring continue to represent dominant segments, while urgent care clinics and retail healthcare centers are becoming key growth channels due to patient demand for accessible and rapid services.
Regional markets show differentiated growth dynamics, with North America maintaining leadership due to regulatory approvals and healthcare infrastructure, while Asia Pacific exhibits strong expansion driven by rising healthcare investments and increasing disease burden. Competitive activity remains intense, with established players strengthening portfolios through R&D and regulatory approvals, while new entrants introduce portable, digital, and AI-integrated testing platforms to address unmet diagnostic needs and expand testing accessibility across diverse healthcare settings.
Segmentation By Product
- Blood Glucose Monitoring
- Infectious Disease Testing
- Cardiometabolic Disease Testing
- Pregnancy & Fertility Testing
- Hematology Testing
- Others
By Sample
- Blood
- Nasal and Oropharyngeal Swabs
- Urine
- Others
By End-User
- Hospital Bedside
- Physician's Office Lab
- Urgent Care & Retail Clinics
- Home & Self Testing
By Region
- North America (By Product, Sample, End-User, and Country/Sub-region)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, Sample, End-User, and Country/Sub-region)
- U.K. (By Product)
- Germany (By Product)
- France (By Product)
- Italy (By Product)
- Spain (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, Sample, End-User, and Country/Sub-region)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Product, Sample, End-User, and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, Sample, End-User, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
- Rest of the Middle East & Africa (By Product)
Table of Content
1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disease Indications - For Key Country/Region
- 4.2. Technological Advancements in the Point of Care Diagnostics
- 4.3. New Product Launches, Key Players
- 4.4. Overview of Regulatory Scenario, Key Countries/ Region
- 4.5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
5. Global Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Blood Glucose Monitoring
- 5.1.2. Infectious Diseases Testing
- 5.1.3. Cardiometabolic Diseases Testing
- 5.1.4. Pregnancy & Fertility Testing
- 5.1.5. Hematology Testing
- 5.1.6. Others
- 5.2. Market Analysis, Insights and Forecast - By Sample
- 5.2.1. Blood
- 5.2.2. Nasal and Oropharyngeal Swabs
- 5.2.3. Urine
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospital Bedside
- 5.3.2. Physician's Office Lab
- 5.3.3. Urgent Care & Retail Clinics
- 5.3.4. Home & Self-testing
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Blood Glucose Monitoring
- 6.1.2. Infectious Diseases Testing
- 6.1.3. Cardiometabolic Diseases Testing
- 6.1.4. Pregnancy & Fertility Testing
- 6.1.5. Hematology Testing
- 6.1.6. Others
- 6.2. Market Analysis, Insights and Forecast - By Sample
- 6.2.1. Blood
- 6.2.2. Nasal and Oropharyngeal Swabs
- 6.2.3. Urine
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospital Bedside
- 6.3.2. Physician's Office Lab
- 6.3.3. Urgent Care & Retail Clinics
- 6.3.4. Home & Self-testing
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 6.4.1. U.S
7. Europe Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Blood Glucose Monitoring
- 7.1.2. Infectious Diseases Testing
- 7.1.3. Cardiometabolic Diseases Testing
- 7.1.4. Pregnancy & Fertility Testing
- 7.1.5. Hematology Testing
- 7.1.6. Others
- 7.2. Market Analysis, Insights and Forecast - By Sample
- 7.2.1. Blood
- 7.2.2. Nasal and Oropharyngeal Swabs
- 7.2.3. Urine
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospital Bedside
- 7.3.2. Physician's Office Lab
- 7.3.3. Urgent Care & Retail Clinics
- 7.3.4. Home & Self-testing
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Product
- 7.4.2. Germany
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Spain
- 7.4.4.1. By Product
- 7.4.5. Italy
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 7.4.1. U.K.
8. Asia Pacific Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Blood Glucose Monitoring
- 8.1.2. Infectious Diseases Testing
- 8.1.3. Cardiometabolic Diseases Testing
- 8.1.4. Pregnancy & Fertility Testing
- 8.1.5. Hematology Testing
- 8.1.6. Others
- 8.2. Market Analysis, Insights and Forecast - By Sample
- 8.2.1. Blood
- 8.2.2. Nasal and Oropharyngeal Swabs
- 8.2.3. Urine
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospital Bedside
- 8.3.2. Physician's Office Lab
- 8.3.3. Urgent Care & Retail Clinics
- 8.3.4. Home & Self-testing
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Product
- 8.4.2. China
- 8.4.2.1. By Product
- 8.4.3. India
- 8.4.3.1. By Product
- 8.4.4. Australia
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 8.4.1. Japan
9. Latin America Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Blood Glucose Monitoring
- 9.1.2. Infectious Diseases Testing
- 9.1.3. Cardiometabolic Diseases Testing
- 9.1.4. Pregnancy & Fertility Testing
- 9.1.5. Hematology Testing
- 9.1.6. Others
- 9.2. Market Analysis, Insights and Forecast - By Sample
- 9.2.1. Blood
- 9.2.2. Nasal and Oropharyngeal Swabs
- 9.2.3. Urine
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospital Bedside
- 9.3.2. Physician's Office Lab
- 9.3.3. Urgent Care & Retail Clinics
- 9.3.4. Home & Self-testing
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 9.4.1. Brazil
10. Middle East & Africa Point of Care Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Blood Glucose Monitoring
- 10.1.2. Infectious Diseases Testing
- 10.1.3. Cardiometabolic Diseases Testing
- 10.1.4. Pregnancy & Fertility Testing
- 10.1.5. Hematology Testing
- 10.1.6. Others
- 10.2. Market Analysis, Insights and Forecast - By Sample
- 10.2.1. Blood
- 10.2.2. Nasal and Oropharyngeal Swabs
- 10.2.3. Urine
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospital Bedside
- 10.3.2. Physician's Office Lab
- 10.3.3. Urgent Care & Retail Clinics
- 10.3.4. Home & Self-testing
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.1.1. By Product
- 10.4.2. South Africa
- 10.4.2.1. By Product
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product
- 10.4.1. GCC
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- 11.2.1. F. Hoffmann-La Roche Ltd.
- 11.2.2. Abbott
- 11.2.3. EKF Diagnostics Holding plc
- 11.2.4. Cardinal Health, Inc.
- 11.2.5. Thermo Fisher Scientific Inc.
- 11.2.6. Quest Diagnostics Incorporated
- 11.2.7. BD
- 11.2.8. bioMerieux SA
- 11.2.9. Bio-Rad Laboratories Inc.
- 11.2.10. QuidelOrtho Corporation
List of Tables
- Table 1: Global Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 3: Global Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 4: Global Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 6: North America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 7: North America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 8: North America Point of Care Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 9: U.S. Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 10: Canada Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 11: Europe Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 12: Europe Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 13: Europe Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 14: Europe Point of Care Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: U.K. Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 16: Germany Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 17: France Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 18: Spain Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 19: Italy Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 20: Scandinavia Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 21: Rest of Europe Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 22: Asia Pacific Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 23: Asia Pacific Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 24: Asia Pacific Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 25: Asia Pacific Point of Care Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Japan Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 27: China Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 28: India Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 29: Australia Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 30: Southeast Asia Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 31: Rest of Asia Pacific Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 32: Latin America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 33: Latin America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 34: Latin America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 35: Latin America Point of Care Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Brazil Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 37: Mexico Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 38: Rest of Latin America Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 39: Middle East & Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 40: Middle East & Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2021-2034
- Table 41: Middle East & Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 42: Middle East & Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 43: GCC Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 44: South Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 45: Rest of Middle East & Africa Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
List of Figures
- Figure 01: Global Point of Care Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 02: Global Point of Care Diagnostics Market Value Share (%), by Product, 2025 & 2034
- Figure 03: Global Point of Care Diagnostics Market Value Share (%), By Sample, 2025 & 2034
- Figure 04: Global Point of Care Diagnostics Market Value Share (%), By End User, 2025 & 2034
- Figure 05: Global Point of Care Diagnostics Market Value (USD billion), By Region, 2025 & 2034
- Figure 06: North America Point of Care Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 07: North America Point of Care Diagnostics Market Value Share (%), by Product, 2025
- Figure 08: North America Point of Care Diagnostics Market Value (USD billion), by Sample, 2025 & 2034
- Figure 09: North America Point of Care Diagnostics Market Value Share (%), by Sample, 2025
- Figure 10: North America Point of Care Diagnostics Market Value (USD billion), by End User, 2025 & 2034
- Figure 11: North America Point of Care Diagnostics Market Value Share (%), by End User, 2025
- Figure 12: North America Point of Care Diagnostics Market Value (USD billion), by Country, 2025 & 2034
- Figure 13: North America Point of Care Diagnostics Market Value Share (%), by Country, 2025
- Figure 14: Europe Point of Care Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: Europe Point of Care Diagnostics Market Value Share (%), by Product, 2025
- Figure 16: Europe Point of Care Diagnostics Market Value (USD billion), by Sample, 2025 & 2034
- Figure 17: Europe Point of Care Diagnostics Market Value Share (%), by Sample, 2025
- Figure 18: Europe Point of Care Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Point of Care Diagnostics Market Value Share (%), by End-user, 2025
- Figure 20: Europe Point of Care Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Point of Care Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Point of Care Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Asia Pacific Point of Care Diagnostics Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Point of Care Diagnostics Market Value (USD billion), by Sample, 2025 & 2034
- Figure 25: Asia Pacific Point of Care Diagnostics Market Value Share (%), by Sample, 2025
- Figure 26: Asia Pacific Point of Care Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Point of Care Diagnostics Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Point of Care Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Point of Care Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Point of Care Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Latin America Point of Care Diagnostics Market Value Share (%), by Product, 2025
- Figure 32: Latin America Point of Care Diagnostics Market Value (USD billion), by Sample, 2025 & 2034
- Figure 33: Latin America Point of Care Diagnostics Market Value Share (%), by Sample, 2025
- Figure 34: Latin America Point of Care Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Point of Care Diagnostics Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Point of Care Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Point of Care Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Point of Care Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Point of Care Diagnostics Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Point of Care Diagnostics Market Value (USD billion), by Sample, 2025 & 2034
- Figure 41: Middle East & Africa Point of Care Diagnostics Market Value Share (%), by Sample, 2025
- Figure 42: Middle East & Africa Point of Care Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Point of Care Diagnostics Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Point of Care Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Point of Care Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Point of Care Diagnostics Market Share (%), By Company, 2025
